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Twelve retinopathy screening
clinics serving 489 diabetic
patients were conducted in three
Michigan communities as part
of the outreach effort of the
Michigan Diabetes Research
and Training Center. Screening
activities were initiated by local
diabetes educators who
conducted a program designed
to promote detection of diabetic
eye disease and increase patient





screening clinics can be
successfully conducted if health
care professionals in the
community consider diabetic
retinopathy to be a serious
problem, one individual is
willing to oversee the
organizational aspects of the
clinic, and an ophthalmologist
with laser treatment capability is
present or nearby. These clinics
are effective in detecting
diabetic eye disease and
facilitating subsequent patient
visits to an ophthalmologist for
evaluation in accordance with
national recommendations.
A decade ago, proliferative retinopathy and other severe
diabetic eye complications frequently led to blindness or
severely impaired vision. Today, laser treatment and vitrec-
tomy are available to treat those disorders. The Diabetic
Retinopathy Study (DRS) demonstrated that laser treatment
initiated in a timely fashion is effective in preserving vision
and ameliorating the severe effects of diabetic retinal dis-
ease.’ Because serious diabetic retinopathy is often asymp-
tomatic and its detection difficult, several recommendations
have been made by the National Diabetes Advisory Board
(NDAB) for routine ophthalmologic examination to ensure
timely detection and treatment. The critical importance of
identification and referral for treatment was emphasized by
the NDAB in its National Plan to Reduce Mortality and
Morbidity of Diabetes .2 Further, there was a substantial ef-
fort to make practicing physicians aware of the DRS Group’s
findings. In 1983, the NDAB published and disseminated a
booklet entitled The Prevention and Treatment of Five Com-
plications of Diabetes: A Guide for Primary Car-e Practition-
~’~ This booklet specifically addresses the prevention,
detection/monitoring, and treatment/referral of diabetic eye
disease. In Michigan, the Department of Public Health in
1984 developed and distributed diabetic retinopathy referral
guidelines for health care providers throughout the state.’
Despite these activities, there was strong evidence that the
guidelines were not being followed at the community level.
A study by Stross and Harlan5 reported that 18 months after
the DRS findings were reported, 72% of family physicians
and 54% of internists were not aware of the study and its
implications for referral and treatment. A survey conducted
in Michigan a year following the dissemination of the reti-
nopathy referral guidelines found that many health profes-
sionals who had received the guidelines had not read them.
Among diabetic individuals surveyed, only 26% reported
that they had been given the complete recommendations for
eye care delineated in the guidelines .6 In the 1985 assess-
ment of the status of diabetes care in Michigan, the review of
the data revealed that, among 261 patients from eight com-
munities, only 59% of patients with diabetes had seen an
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ophthalmologist at some time and only 54% had seen one
within the last 2 years.’
In an effort to address this problem, screening for retinop-
athy has been undertaken by a number of groups to detect
previously unrecognized disease and to highlight the impor-
tance of annual ophthalmologic evaluation. These studies
have been conducted using a mobile examination van and/or
personnel who perform fundus photography in the field, with
subsequent evaluation of the photographs by an ophthalmol-
ogist. 8-10 This format has been efficacious in identifying
cases of diabetic eye disease and has other benefits as well;
screening activities that use a mobile examination van allow
evaluation of large numbers of people in geographically
dispersed areas, and the use of fundus photography helps to
resolve the issue of labor-intensive screening by health pro-
fessionals whose services may be difficult to acquire on a
volunteer basis. However, many communities lack the finan-
cial resources to purchase such equipment and may wish to
consider other alternatives.
The retinopathy screening experience described in this
report provides another model for conducting screening at
the community level. This paper will describe the compo-
nents of a community-based retinopathy screening clinic, the
role of the diabetes educator to initiate the project and mobi-
lize the necessary resources, and the significant patient find-
ings that demonstrate the value of such an undertaking.
Research Design and Methods
As part of the outreach effort of the Michigan Diabetes
Research and Training Center (MDRTC), diabetes advisory
councils (DACs) have been developed in each of six com-
munities randomly selected within the state of Michigan.
Each council has representatives from the local diabetes
community, including health professionals and consumers
interested in diabetes. Council members, in collaboration
with the staff of the MDRTC, study the diabetes care in their
own communities, noting problems and trends in diabetes
care and addressing them through the development of pro-
grams at the community level. Three DACs were particu-
larly concerned that the national recommendations
regarding ophthalmologic care for persons with diabetes
were not being met. To promote detection of ophthalmologic
disease among people with diabetes, 12 retinopathy screen-
ing clinics serving 489 diabetic patients were conducted in
these three communities over the course of 2 years.
In each community, a diabetes educator from a local hos-
pital assumed responsibility for organizing the clinic. Space
was provided by the hospital or a community ophthalmolo-
gist, and the diabetes educator handled the advance public-
ity. To announce the availability of the clinics, diabetes
educators developed fliers that were mailed to and posted in
primary care physicians’ offices. Each physician also re-
ceived a letter that detailed the diabetic retinopathy referral
guidelines and encouraged the physician to follow the guide-
lines, if not already doing so. Notices were placed in the
newspaper, public service announcements were made on
radio and television; and posters were displayed in various
locations such as pharmacies, clinics, and other community
locations. In some instances, personal mailings were made to
members of diabetes patient support groups. Not all public-
ity measures were used in each community.
The local chapter of the American Diabetes Association or
the diabetes educator scheduled the patient appointments
and assembled the necessary volunteer assistance from
among local health professionals. Volunteers generally in-
cluded ( 1 ) someone to check the patients in and coordinate
patient flow through all stations, (2) interviewers to review
the medical and diabetes history questionnaire with each
patient, (3) a nurse or technician to obtain random blood
glucose and physical assessment measures, (4) a nurse or
technician to conduct visual acuity assessments and instill
eye drops, and (5) the ophthalmologist and a person to assist
the ophthalmologist in conducting the fundus examination
and tonometry.
Ophthalmologist recruitment was conducted by advisory
council members. Council members selected the ophthal-
mologist currently providing the most diabetes ophthalmo-
logic care to the people of that community. These
ophthalmologists were usually well known to the medical
community and had laser treatment capabilities in their prac-
tices. The ophthalmologists were invited to volunteer their
time to provide ophthalmologic exams at the screening clin-
ics and were willing to participate.
The number of patients scheduled varied by community
according to the number of volunteers and physical space
available. In one community, a volunteer staff of eight per-
sons (excluding the ophthalmologist) was assembled, the
clinic was held in the office suite of the community’s only
ophthalmologist, and I patient could be scheduled every 5
minutes. In another community, only five volunteers were
obtained; the clinic occupied a portion of the hospital corri-
dor and two treatment rooms usually reserved for the Emer-
gency Department. Because of the limited space, 1 patient
could be scheduled every 10 minutes. In another community,
the clinic was held in the education corridor of one of the
community hospitals, occupying a suite of offices and con-
ference rooms. Here I patient was scheduled every 5 min-
utes. Generally, the ophthalmologists could comfortably
screen 12 patients per hour. Fewer patients were scheduled if
space and volunteer restrictions necessitated such a decision.
An advance mailing, which included a confirmation of the
appointment and an interview questionnaire, was sent to
each patient. A 52-item medical history questionnaire was
used. Patients were asked to complete the questionnaire and
bring it with them to the clinic. Height, weight, blood pres-
sure, heart rate, and blood glucose values were determined.
Blood for cholesterol, triglyceride, serum creatinine, C-pep-
tide, and HbA, measurement was drawn and taken back to
the laboratories of the MDRTC to be analyzed. Visual acuity
and intraocular pressure were assessed. Each patient
received a complete funduscopic examination by the oph-
thalmologist. It should be noted that some of these steps and
blood tests were conducted by the MDRTC staff for re-
search purposes and are not integral to replication in all
communities.
Those persons with ophthalmologic findings requiring
further attention were instructed to seek an appointment for
further evaluation with an area ophthalmologist within a
specified time period. Those without serious findings were
advised to have their eyes checked on an annual basis. The
importance of annual ophthalmologic evaluation was rein-
forced. Each patient and his or her physician were sent the
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results of the ophthalmologic examination and the blood
analysis.
To evaluate the effectiveness of the clinic, all patients with
serious findings at any of the clinics were contacted by
phone. These patients had been seen at screening clinics
from 6 months to 3 years prior to the telephone follow-up.
All others (ie, those without serious findings) were contacted
by mail to determine their follow-through with the recom-
mendation that they seek an annual ophthalmologic exam.
Patients seen within the previous year, with either less seri-
ous findings or normal exams, were not contacted because
their &dquo;annual&dquo; ophthalmologic exam would not be due yet.
Results
Clinic Activity and Data Set Overall, there were 552 vis-
its to the screening clinics. Two communities each con-
ducted five clinics consisting of 415 screening visits.
However, both of those communities experienced significant
repeat rates (17% and 14%). In the other community, efforts
were made to limit patients to one screening visit. They
conducted two clinics, screening a total of 137 patients. The
data set consists of 489 patients; repeat visits were not in-
cluded. Also, the communities used different age-eligibility
criteria (ie, one community allowed children to be screened,
one allowed adolescents, and one required that the patients
be adults). For purposes of uniformity, patients under 21 1
years of age were eliminated from the data set.
Effectiveness of Publicity Measures Extensive publicity
measures were employed in each community, although not
all communities used identical methods. To determine which
publicity methods were most effective, patients were asked,
&dquo;How did you first hear about the clinic?&dquo; Their responses
are displayed in Table 1.
To ascertain what motivated the patients to attend the
clinic, they were asked, &dquo;What was the most important rea-
son you came to the clinic today?&dquo; The responses to this
question are displayed in Table 2.
Patient Findings Table 3 displays the characteristics of the
patients seen in the screening clinics.
Demographics Insulin-dependent diabetes patients were
defined as insulin using, younger than age 40 at diagnosis of
diabetes, less than 135% of ideal body weight, and having a
random C-peptide value of <0.6 iig/mL. In terms of the racial
distribution, 96% of patients screened were white and 2%
were black. Although this distribution is not representative
of the general population in Michigan, it reflects the popula-
tion distribution of small, rural communities where the ma-
jority of screening took place. Attempts were made to
provide working individuals ample opportunity to attend the
screening clinics by holding some screenings on Saturdays
and during evening hours.
Ophthalmologic Findings Forty-three percent of all pa-
tients had seen an ophthalmologist at some time in their life
to check on the effects of diabetes on their eyes; 39% had
seen an ophthalmologist in the past 2 years. Only 26% had
ever been referred to an ophthalmologist by their physician.
Among the 61 % of patients who hadn’t been to an ophthal-
mologist in the past 2 years, the largest number (43%) re-
sponded that they were not sent by their physician. An addi-
tional 20% did not feel it was important, and 41 % didn’t
know they were supposed to consult an ophthalmologist.
Only 16% reported cost as a reason for not seeking ophthal-
mologic evaluation. (Note: More than one answer was possi-
ble ; hence, percentages add up to more than 100.)
Ophthalmologic abnormalities were identified in 50% of
the people seen: 58% of those with insulin-dependent diabe-
tes mellitus (IDDM) and 48% of those with non-insulin-
dependent diabetes mellitus (NIDDM) had ophthalmologic
findings. Normal retinas were found in 246 patients (50%).
Proliferative or preproliferative retinopathy was found in 11 I
(2%) of those seen, macular edema in 6 patients ( 1 %), vitre-
ous hemorrhage in 3 patients (<1 %), background retinopathy
in 140 patients (29%), cataracts in 66 patients (13%), and
other findings, including increased intraocular pressure, pig-
ment changes, age-related degeneration, retinal changes of
high blood pressure, and &dquo;other&dquo; were seen in 15% of the
patients. (Percentages add up to more than 100 because some
patients had more than one finding.) Ophthalmologic find-
ings are displayed in Table 4.
Twenty patients (4%) were identified as having serious
findings. These findings included proliferative and pre-
proliferative retinopathy ( 11 patients), vitreous hemorrhage
(3 patients), and macular edema (6 patients). Among these
20 patients, only 6 reported that they knew diabetes had
affected their eyes. Ten of these patients reported that they
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had seen an ophthalmologist within the last 2 years, and five
reported that they had never seen an ophthalmologist before
their attendance at this clinic.
Fo//<3n’-M/? Each patient and his or her physician were sent
the results of the ophthalmologic examination and the blood
analysis. One hundred fifty-three physicians received re-
ports on their patients.
Patients with serious findings at any of the clinics were
contacted by phone to determine their follow-through with
recommendations to seek immediate treatment. Telephone
follow-up occurred on two occasions from 6 months to 3
years following the clinic visit. Fourteen of the 20 patients
with serious findings were successfully contacted. Among
these 14 patients, 1 had not returned to the ophthalmologist
because of extensive illness; 1 did not see the ophthalmolo-
gist as recommended, but subsequently did receive treatment
for retinopathy; and the other 11 did see an ophthalmologist
as recommended. Of those 11 patients, 1 has become blind
since the clinic, 5 have had surgery and/or laser photocoagu-
lation, and 5 are being closely monitored. Among the 6
patients not contacted by telephone, 3 were seen at subse-
quent clinics. They continue to be monitored in the clinic
setting. Three patients were lost to the study. They could not
be located at the address and phone number they had pro-
vided, and other attempts to locate them were unsuccessful.
Follow-up postcards were sent to those patients who had
been screened at least 1 year ago and who did not have
serious findings. The postcard asked the patients how many
times they had been to an ophthalmologist since attending
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the Diabetes Eye Clinic and if they had had laser treatments
since attending the Diabetes Eye Clinic. Postcards were sent
to 351 people and were returned by 258 people for a re-
sponse rate of 74%. Of those who responded, 70% had
returned to see an ophthalmologist at least once since the
clinic.
Discussion
Twelve retinopathy screening clinics were successfully or-
ganized and implemented under the direction of local diabe-
tes educators. Through effective publicity measures, full
clinic schedules were easily generated in each community.
The newspaper, the physician, and the diabetes educator
were the most commonly mentioned sources of information
about the clinics. Physician notification of the availability of
the screening clinics served as an effective publicity measure
for patients and had the secondary effect of disseminating
ophthalmologic referral guidelines to the physician commu-
nity. Over the course of the project, 153 physicians received
follow-up information regarding the status of their patients
seen at the retinopathy clinics.
The majority of patients (62%) attended the clinic to see if
diabetes was affecting their eyes. The screening clinics made
it possible for diabetes educators to provide on-site patient
teaching, not only about the importance of annual ophthal-
mologic evaluation, but about other areas of diabetes man-
agement as well. Many patients (41 %) had never
participated in available diabetes education programs; the
clinics fostered patient awareness of these valuable commu-
nity resources. Aside from providing the opportunity to re-
cruit patients to diabetes education in the community, these
screening clinics also enabled diabetes educators to establish
a more extensive mailing list for future activities and permit-
ted the distribution of pertinent patient education materials.
Further, obtaining other health information such as blood
pressure and lipid measurements alerted patients, the diabe-
tes educator, and the physician to other potential health
concerns.
Ophthalmologic abnormalities were identified in 50% of
those attending the screening clinics. Half of the patients
(50%) had normal retinas, and background retinopathy was
detected among 28% of patients. Severe disease was found
in 4% of those screened and, among those 20 patients, 5
reported that they had never seen an ophthalmologist to
evaluate the effect of diabetes on their eyes. Thus, screening
clinics may not uncover large quantities of undetected dis-
ease and may, in fact, serve as &dquo;interim visits&dquo; to those
already under ophthalmologic care for serious conditions.
Nevertheless, it was the experience in each screening clinic
that less than half of the patients had ever seen an ophthal-
mologist. Even fewer (26%) reported being referred to an
ophthalmologist by their physician. Their attendance at the
screening clinic provided an opportunity to learn about the
possible effects of diabetes on the eyes, the availability of
effective treatment measures for detected disease, and the
importance of monitoring for these effects on a yearly basis.
Follow-up with clinic participants was conducted to as-
certain the effectiveness of this activity in promoting adher-
ence to the recommendation of annual ophthalmologic
evaluation. Seventy percent of those responding to our post-
card follow-up indicated that they had returned to the oph-
thalmologist at least once since their clinic attendance. Prior
to the screening clinic, 51 % of these individuals had never
been examined by an ophthalmologist.
From the positive experience in generating health profes-
sional and patient interest in a screening program and the
significant educational rewards that are gained from it, it is
reasonable to conclude that community-based retinopathy
screening is a worthwhile endeavor. However, several
themes emerged from the experience in conducting screen-
ing clinics in communities of different sizes. It is apparent
that certain conditions within the professional community
must be in place in order to conduct such clinics success-
fully. These characteristics include:
1. The health care professionals in the community must
consider diabetic r-etinopathy to be a serious problem. Mem-
bers of the Diabetes Advisory Councils in each of the com-
munities were given data on the status of ophthalmologic
care as assessed during our study of physicians and patients
during the 1981-1985 period. Referral patterns of primary
care physicians, patients’ self-reports of frequency of visits
to an ophthalmologist, purpose of the visit(s), and reasons
for seeking or not seeking routine ophthalmologic evalua-
tion were presented. Overall, barely half of all patients with
NIDDM had ever seen an ophthalmologist and even fewer
had received ophthalmologic evaluation within the past 2
years. Further, many patients indicated that they were not
aware of the need to receive such an evaluation annually;
many patients confused optometrists with ophthalmologists,
and many reported that their physicians had not informed
them of the need for this evaluation.
After reviewing the data, council members in several
communities voiced an interest in conducting screening clin-
ics. They expressed concern not only about unrecognized
disease in their communities but also about patient and pro-
fessional unawareness of the accepted guidelines for routine
ophthalmologic evaluation. In these communities, council
members were in agreement about the severity of the prob-
lem, and planning for screening activities was undertaken. In
communities where council members did not find the data to
be of great concern, or their perceptions of the potential
difficulties in doing a screening program outweighed their
interest in the problem, screening did not take place.
2. There must be one individual willing to coordinate the
organizational aspects of the clinic. An essential component
was the presence of one individual willing to oversee organi-
zational issues. In all participating communities, the local
diabetes educator assumed this role. Despite significant
DRTC assistance with preparation of correspondence to pa-
tients and physicians, development of interview and exami-
nation forms, and so forth, the diabetes educator took the
lead in securing the facility for screening, arranging volun-
teer assistance, and attending to the myriad of details that
accompanied a project of this nature. In small communities
with only one hospital and usually one educator, selection of
the coordinator was not a problem. In large communities
with several competing hospitals, however, there were con-
flicts involved in having a hospital-employed diabetes edu-
cator assume the responsibilities of organizing a
&dquo;community&dquo; project. Although the activity was part of the
educator’s role as a Diabetes Advisory Council member, the
educator was viewed as a representative of a particular hos-
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pital. For convenience, that hospital was also chosen as the
site for conducting the screening. It therefore appeared to the
community that the screening clinic was a function of the
hospital and this became a source of tension among the
health care professionals in the area. This was generally
resolved by planning to rotate screening sites and coordina-
tors. Regardless of community size, however, it was neces-
sary that someone within that community take responsibility
for planning.
3. An ophthalmologist who has laser treatment capability
must be present or nearby. We learned that a particular com-
munity size or the presence of an ophthalmologist within that
community is not necessary for a successful screening pro-
gram. However, if a community has an ophthalmologist, he
or she must have laser treatment capabilities in the office and
be willing to participate in the project. Short of this, a willing
ophthalmologist with laser equipment must be found else-
where.
In one community, optimal conditions were in place. The
only practicing ophthalmologist in town had an office suite
that was well staffed and fully equipped for laser treatment.
He offered his office as the site for screening clinics and
conducted screening examinations along with office visits
from patients in his regular caseload.
Another small community with one community hospital
and one diabetes educator had no ophthalmologist. How-
ever, an ophthalmologist from a larger community approxi-
mately 100 miles away expressed willingness to participate
in the screening project. He had laser treatment equipment in
his office.
In a third small community, two ophthalmologists were
approached to determine their interest in participating in
screening clinics. Neither ophthalmologist had access to
laser equipment. Both declined to participate and were very
clear about their reasons for this decision. Providing ophthal-
mologic evaluations at no charge for many people in the
community with diabetes would reduce their regular
caseload, and any patients detected with significant retinopa-
thy would have to be referred to another ophthalmologist in
another community for treatment. Although council mem-
bers cited the benefits of visibility, community service, and
the potential for new patient recruitment for routine ophthal-
mologic care and treatment of conditions not requiring laser
therapy, both ophthalmologists were firm in their decision
not to participate.
In one large community with several hospitals and oph-
thalmologists with laser capabilities in their offices, the
council had no difficulty in recruiting a volunteer. However,
to alleviate the concern of some ophthalmologists that the
volunteer would &dquo;get all the referrals,&dquo; a list of all ophthal-
mologists in the city and the hospital(s) at which they prac-
ticed was distributed to all patients.
Education of people with diabetes and their health care
providers is integral to resolving the problem of vision loss
from diabetic eye disease. Community-based screening clin-
ics provide an opportunity for local health professionals to
detect diabetic eye disease and uncover other potential
health risks in the diabetic population. Messages about ac-
cepted ophthalmic evaluation guidelines can also be effec-
tively delivered to patients while disseminating the same
guidelines to their physicians during clinic publicity and in
follow-up. Patient awareness of available diabetes education
resources and other hospital services is also fostered in this
setting. This screening model affords the opportunity for
diabetes educators and other interested health professionals
to provide community service, education related to eye care,
and information about other important topics in diabetes
management.
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